Hinge Health, Inc. reported $720M of revenue over the trailing twelve months, +50% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $720M (to Q2 2026). Net income: $109M, trailing twelve months to Q2 2026. Free cash flow: $290M, trailing twelve months to Q2 2026. Operating margin: 12%, trailing twelve months to Q2 2026.

HNGEHinge Health, Inc.

Healthcare

$102.86+81% 1Y

$102.86

$31.1752 weeks$102.86

Latest close: a new 52-week highOct 9, 2026what changed →

HNGE as reported

Hinge Health, Inc. reported $720M of revenue over the trailing twelve months, +50% on the year before. 9 reported series are charted on this page, each one as filed.

$720M

Revenue, trailing twelve months · to Q2 2026 · +50% against the twelve months before

Net income: $109M
Net income · −121% year on year · trailing twelve months to Q2 2026
Free cash flow: $290M
Free cash flow · +218% year on year · trailing twelve months to Q2 2026
Operating margin: 12%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for HNGE, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$720M	+50%	Q2 2026
Net income	$109M	−121%	Q2 2026
EPS	$3.02	−131%	Q2 2026
Gross margin	84%	n/a	Q2 2026
Operating margin	12%	n/a	Q2 2026
Net margin	14%	n/a	Q2 2026
ROE	−244%	n/a	Q2 2026
ROA	−49%	n/a	Q2 2026
Free cash flow	$290M	+218%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.